Skip to main content
. 2022 Feb 25;6(5):1420–1431. doi: 10.1182/bloodadvances.2021006208

Table 2.

Cox regression analysis for baseline characteristics in NA-ACCORD (N = 717) and COMPLETE (N = 450)

Multivariate analysis Univariate analysis
Variable HR (95% CI) P HR (95% CI) P
HIV infection* (yes, no) 1.92 (1.27, 2.91) .002 1.80 (1.25, 2.59) .001
Age (y) 1.02 (1.01, 1.03) <.001 1.01 (1.01, 1.02) .002
Female sex (yes, no) 1.00 (0.77, 1.30) .98
Race
 Black (yes, no) 1.65 (1.19, 2.29) .002 1.72 (1.26, 2.35) <.001
 Other 1.75 (1.11, 2.77) .02 1.60 (1.02, 2.52) .04
CKD§ (yes, no) 1.35 (0.74, 2.47) .33
HBVǁ (yes, no) 2.10 (1.04, 4.25) .04
HCVǁ (yes, no) 1.90 (1.06, 3.39) .03
ATLL (yes, no) 1.45 (0.75, 2.83) .27
ALCL (yes, no) 0.55 (0.37, 0.80) .002 0.59 (0.42, 0.84) .004
AITL (yes, no) 1.12 (0.80, 1.56) .52
CTCL (yes, no) 1.19 (0.74, 1.89) .48
NK/TCL (yes, no) 0.89 (0.58, 1.36) .59
PTCL-NOS (yes, no) 1.35 (1.04, 1.74) .02
*

Reference group: non-HIV.

Reference group: male.

Reference group: White.

§

Patients with CKD were defined as those who ever had an eGFR consistently <60 mL/min per 1.73 m2 for at least 3 months.

ǁ

HBV, hepatitis B virus, as determined by detection of surface antigen, e antigen, or DNA quantification; HCV, hepatitis C virus as determined by detection of antibody, RNA quantification, or genotype.